Plunkett Research Online: Aptevo Therapeutics

APTEVO THERAPEUTICS (APVO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Aptevo Therapeutics Inc is a clinical-stage biotechnology company. It focuses on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. The company develops its drug candidates using its ADAPTIR platform. The products under its pipeline are APVO436, which targe.....



Aptevo Therapeutics
Ticker: APVO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 206 838-0500
Fax: 206 838-0503
Address: 2401 4th Avenue
Suite 1050
Seattle, WA 98121 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
Contacts Description
Marvin White CEO/Director/President
Jeffrey Lamothe CFO/Chief Accounting Officer/Executive VP
See More
Aptevo Therapeutics Inc is a clinical-stage biotechnology company. It focuses on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. The company develops its drug candidates using its ADAPTIR platform. The products under its pipeline are APVO436, which targe.....See More See More

Auditor: Moss Adams LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2021 2020 2019 2018 2017 2016
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: